GALLIUM DOTATATE GA-68
| Brand name | NETSPOT |
|---|---|
| Active ingredient | GALLIUM DOTATATE GA-68 |
| Strength | 2.1-5.5mCi/ML |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | June 2016 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9375498 | August 2032 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.